White Bear Lake, MN -Chemi Nutra announces the filing of a methods and compositions patent related to alpha-glyceryl phosphoryl choline (A-GPC) and its effects on altering body composition.
Scott Hagerman, president of Chemi Nutra said, “This patent filing demonstrates Chemi’s commitment to the nutritional supplement industry, and will be backed by continued research that will provide more definitive answers to how A-GPC can effectively assist people in modifying their physiques.” It is well known that weight-loss and sports nutrition are two of the most exciting product categories that exist in the natural products industry. AlphaSize™, Chemi’s branded A-GPC, is poised as one of the most interesting new ingredient compounds that fits clearly into both of these categories.
Chemi Nutra is the new US branch of parent company Chemi S.p.A., a privately held pharmaceutical and nutraceutical company based in Milan, Italy. Chemi, with cGMP certified manufacturing facilities in Italy and Brazil, is best known in the US nutritional arena for its introduction of phosphatidyl serine (PS), the popular dietary supplement used to enhance learning, memory, and concentration.